Return to content in this issue


Excipients as Potential Agents of Anaphylaxis in Vaccines: Analyzing the Formulations of Currently Authorized COVID-19 Vaccines

Caballero ML, Quirce S

Department of Allergy, La Paz University Hospital, IdiPAZ, Madrid, Spain

J Investig Allergol Clin Immunol 2021; Vol 31(1) : 92-93
doi: 10.18176/jiaci.0667

Key words: Allergy, Anaphylaxis, Coronavirus, COVID-19, Immediate drug hypersensitivity reaction, Excipient, Pharmaceutical excipients, Vaccine